159 related articles for article (PubMed ID: 32615290)
1. Mitotic Index and Progression-Free Survival in Atypical Meningiomas.
Domingo RA; Tripathi S; Vivas-Buitrago T; Lu VM; Chaichana KL; Quiñones-Hinojosa A
World Neurosurg; 2020 Oct; 142():191-196. PubMed ID: 32615290
[TBL] [Abstract][Full Text] [Related]
2. Risk factors associated with postoperative recurrence in atypical intracranial meningioma: analysis of 263 cases at a single neurosurgical centre.
Wang F; Xu D; Liu Y; Lin Y; Wei Q; Gao Q; Lei S; Guo F
Acta Neurochir (Wien); 2019 Dec; 161(12):2563-2570. PubMed ID: 31641861
[TBL] [Abstract][Full Text] [Related]
3. Meningioma grading: an analysis of histologic parameters.
Perry A; Stafford SL; Scheithauer BW; Suman VJ; Lohse CM
Am J Surg Pathol; 1997 Dec; 21(12):1455-65. PubMed ID: 9414189
[TBL] [Abstract][Full Text] [Related]
4. Atypical Meningiomas: Histologic and Clinical Factors Associated With Recurrence.
Ros-Sanjuan A; Iglesias-Moroño S; Carrasco-Brenes A; Bautista-Ojeda D; Arraez-Sanchez MA
World Neurosurg; 2019 May; 125():e248-e256. PubMed ID: 30684705
[TBL] [Abstract][Full Text] [Related]
5. Clinical and histopathological predictors of outcome in malignant meningioma.
Maier AD; Bartek J; Eriksson F; Ugleholdt H; Juhler M; Broholm H; Mathiesen TI
Neurosurg Rev; 2020 Apr; 43(2):643-653. PubMed ID: 30868425
[TBL] [Abstract][Full Text] [Related]
6. Skull base atypical meningioma: long term surgical outcome and prognostic factors.
Wang YC; Chuang CC; Wei KC; Hsu YH; Hsu PW; Lee ST; Wu CT; Tseng CK; Wang CC; Chen YL; Jung SM; Chen PY
Clin Neurol Neurosurg; 2015 Jan; 128():112-6. PubMed ID: 25486076
[TBL] [Abstract][Full Text] [Related]
7. Preoperative and Histological Predictors of Recurrence and Survival in Atypical Meningioma After Initial Gross Total Resection.
Loewenstern J; Shuman W; Rutland JW; Kessler RA; Kohli KM; Umphlett M; Pain M; Bederson J; Fowkes M; Shrivastava RK
World Neurosurg; 2019 Aug; 128():e148-e156. PubMed ID: 30995555
[TBL] [Abstract][Full Text] [Related]
8. Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
Rydzewski NR; Lesniak MS; Chandler JP; Kalapurakal JA; Pollom E; Tate MC; Bloch O; Kruser T; Dalal P; Sachdev S
Cancer; 2018 Feb; 124(4):734-742. PubMed ID: 29131312
[TBL] [Abstract][Full Text] [Related]
9. The combination of mitotic and Ki-67 indices as a useful method for predicting short-term recurrence of meningiomas.
Takahashi JA; Ueba T; Hashimoto N; Nakashima Y; Katsuki N
Surg Neurol; 2004 Feb; 61(2):149-55; discussion 155-6. PubMed ID: 14751627
[TBL] [Abstract][Full Text] [Related]
10. Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies.
Puripat N; Loharamtaweethong K
Virchows Arch; 2019 Jan; 474(1):87-96. PubMed ID: 30267302
[TBL] [Abstract][Full Text] [Related]
11. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.
Palma L; Celli P; Franco C; Cervoni L; Cantore G
J Neurosurg; 1997 May; 86(5):793-800. PubMed ID: 9126894
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant radiotherapy versus observation following gross total resection for atypical meningioma: a systematic review and meta-analysis.
Chun SW; Kim KM; Kim MS; Kang H; Dho YS; Seo Y; Kim JW; Kim YH; Park CK
Radiat Oncol; 2021 Feb; 16(1):34. PubMed ID: 33596974
[TBL] [Abstract][Full Text] [Related]
13. Early adjuvant radiotherapy in the treatment of atypical meningioma.
Jenkinson MD; Waqar M; Farah JO; Farrell M; Barbagallo GM; McManus R; Looby S; Hussey D; Fitzpatrick D; Certo F; Javadpour M
J Clin Neurosci; 2016 Jun; 28():87-92. PubMed ID: 26775147
[TBL] [Abstract][Full Text] [Related]
14. Histopathological predictors of progression-free survival in atypical meningioma: a single-center retrospective cohort and meta-analysis.
Kim MS; Chun SW; Dho YS; Seo Y; Lee JH; Won JK; Kim JW; Park CK; Park SH; Kim YH
Brain Tumor Pathol; 2022 Apr; 39(2):99-110. PubMed ID: 35031884
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Postoperative Radiotherapy in Patients with Atypical Meningiomas After Gross Total Resection: Analysis of 260 Cases.
Zeng Q; Tian Z; Gao Q; Xu P; Shi F; Zhang J; Guo Z
World Neurosurg; 2022 Jun; 162():e580-e586. PubMed ID: 35307589
[TBL] [Abstract][Full Text] [Related]
16. Predictors of early progression of surgically treated atypical meningiomas.
Budohoski KP; Clerkin J; Millward CP; O'Halloran PJ; Waqar M; Looby S; Young AMH; Guilfoyle MR; Fitzroll D; Devadass A; Allinson K; Farrell M; Javadpour M; Jenkinson MD; Santarius T; Kirollos RW
Acta Neurochir (Wien); 2018 Sep; 160(9):1813-1822. PubMed ID: 29961125
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcomes of 17 patients with atypical spinal meningioma, including 4 with metastases: a retrospective observational study.
Noh SH; Kim KH; Shin DA; Park JY; Yi S; Kuh SU; Kim KN; Chin DK; Kim KS; Yoon DH; Cho YE
Spine J; 2019 Feb; 19(2):276-284. PubMed ID: 29906618
[TBL] [Abstract][Full Text] [Related]
18. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases.
Fukushima S; Terasaki M; Sakata K; Miyagi N; Kato S; Sugita Y; Shigemori M
Brain Tumor Pathol; 2009; 26(2):51-7. PubMed ID: 19856215
[TBL] [Abstract][Full Text] [Related]
20. Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional Analysis.
Lamba N; Hwang WL; Kim DW; Niemierko A; Marciscano AE; Mehan WA; Benayoun MD; Curry WT; Barker FG; Martuza RL; Dunn IF; Claus E; Bi WL; Aizer AA; Alexander BM; Oh KS; Loeffler JS; Shih HA
World Neurosurg; 2020 Jan; 133():e804-e812. PubMed ID: 31605839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
